H. K. Gillespie - Concepedia

Author

H. K. Gillespie

United States Department of Veterans Affairs

Also Known As

H Gillespie, H K GILLESPIE, H K Gillespie, H. Gillespie, H. K. GILLESPIE, H. K. Gillespie, H.K. Gillespie, HK Gillespie, Hamp Gillespie, Hamp K. GILLESPIE

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

United States Department of Veterans Affairs Palo Alto Veterans Institute for Research Karolinska Institutet Stanford University Södertälje Sjukhus

About

H. K. Gillespie is an author at United States Department of Veterans Affairs specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.1K
2	Social Sciences	7	7	447
3	Health Sciences	6	6	534
4	Cellular Physiology	1	1	11
5	Cognitive Science	1	1	87

H. K. Gillespie

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking Annika Ohlsson, J.‐E. Lindgren, A. Wahlén, Clinical Pharmacology & Therapeutics	1980	474
Comparison of tetrahydrocannabinol and synhexyl in man Leo E. Hollister, R. K. Richards, H. K. Gillespie Clinical Pharmacology & Therapeutics Cannabis UseMolecular PharmacologySubstance AbusePsychoactive DrugSynthetic Isomer	1968	195
Do Plasma Concentrations of Δ<sup>9</sup>‐Tetrahydrocannabinol Reflect the Degree of Intoxication? Leo E. Hollister, H. K. Gillespie, Annika Ohlsson, The Journal of Clinical Pharmacology Substance UsePeak ConcentrationPharmacotherapyPharmacological StudyDrug Test	1981	161
Clinical effects and plasma levels of ?9-Tetrahydrocannabinol (?9-THC) in heavy and light users of cannabis Jan‐Erik Lindgren, Agneta Ohlsson, Stig Agurell, Psychopharmacology Cannabis UseSubstance AbuseLight UsersHealth SciencesPlasma Levels	1981	152
Marihuana and Temporal Disintegration Frederick T. Melges, Jared Tinklenberg, Leo E. Hollister, Science	1970	140
Delta‐8‐ and delta‐9‐tetrahydrocannabinol; Comparison in man by oral and intravenous administration Leo E. Hollister, H. K. Gillespie Clinical Pharmacology & Therapeutics Cannabis UseMolecular PharmacologyPsychoactive DrugIntravenous AdministrationPsychiatry	1973	130
Interactions ofΔ 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography Stig Agurell, Sten Carlsson, J.‐E. Lindgren, Cellular and Molecular Life Sciences Cannabis UsePsychoactive DrugMedicineNeuropharmacologyOral Administration	1981	127
Marijuana and Immediate Memory J. R. Tinklenberg, Frederick T. Melges, Leo E. Hollister, Nature Cannabis UseCognitive ScienceHealth SciencesAddictionMemory Loss	1970	87
Terminal elimination plasma half-life of ?1-tetrahydrocannabinol (?1-THC) in heavy users of marijuana Eva Johansson, Magnus M. Halldin, Stig Agurell, European Journal of Clinical Pharmacology Cannabis UseSubstance AbuseHealth SciencesAddictionMedicine	1989	66
An hallucinogenic amphetamine analog (DOM) in man Leo E. Hollister, M. F. Macnicol, H. K. Gillespie Psychopharmacology Hallucinogenic Amphetamine AnalogPsychoactive DrugAddictionMedicineClub Drug	1969	55

Page 1